Level Biotechnology AAQS

Que fait Level Biotechnology ? Level Biotechnology Inc is a company based in Taipei, Taiwan, operating within the Health Care sector. It went public on September 10, 2004, with its ticker symbol 3118.TWO and ISIN TW0003118006. The company provides biotechnological services, focusing on products such as cell culture series, immune protein series, gene nucleic acid and molecular biology series, and instrument series. Additionally, Level Biotechnology offers preclinical testing services, including genetic toxicity testing, general toxicology testing, reproductive toxicology testing, pharmacokinetic testing, and biocompatibility testing. The company's website is https://www.level.com.tw/index_tw.php. Level Biotechnology operates primarily in the domestic market, serving clients within Taiwan. It is headquartered in Taipei, New Taipei, as stated in the provided information. The company's services and products are designed to support research and development in the biotechnology and health care fields. No additional details about founding year, key personnel, acquisitions, or specific financial figures are provided in the given data. The company's activities are centered around delivering specialized biotechnological solutions to its market. Level Biotechnology est l'une des entreprises les plus populaires sur Eulerpool.